Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer. Read more about Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.
Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation. Read more about Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation.
Targeting immune hubs to advance cancer immunotherapy. Read more about Targeting immune hubs to advance cancer immunotherapy.
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy. Read more about Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine. Read more about A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Read more about Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.
T cell receptor precision editing of regulatory T cells for celiac disease. Read more about T cell receptor precision editing of regulatory T cells for celiac disease.
The T cell receptor landscape of childhood brain tumors. Read more about The T cell receptor landscape of childhood brain tumors.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Read more about Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency. Read more about Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
